Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSickness and diarrhoea are the most commonly reported side effects of Wegovy, affecting a significant proportion of people in the first weeks of treatment, particularly after starting or increasing the dose. The NHS medicines page for semaglutide lists nausea, vomiting and diarrhoea as common effects of the GLP-1 receptor agonist. For most people they're temporary. Understanding the pattern — why symptoms appear, how long they tend to last, and which signs mean something more serious — helps you get through the early weeks without unnecessary anxiety or, on the other side, unnecessary risk.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works partly by slowing how quickly the stomach empties. That's useful for appetite control, but the gut notices the change. The result, especially in the first four to eight weeks or after a dose step, is a cluster of symptoms: nausea is the most common, followed by diarrhoea, constipation, bloating, indigestion and burping. Vomiting happens in a smaller but still significant number of people.
The dose-escalation schedule exists precisely because of this. Starting at 0.25 mg gives the body a settling-in period before the therapeutic doses begin. Each step up carries its own adjustment phase, so symptoms that faded at one dose can briefly return at the next.
Knowing the timeline helps. For most people, nausea peaks in the first one to three days after an injection and fades over the following week. Diarrhoea tends to follow a similar arc. If you want detail on the duration, how long Wegovy sickness typically lasts is covered separately. The broader picture of all reported effects is on the Wegovy side effects page.
That said: if you're feeling rotten right now and you weren't sure this was coming, that's understandable. It's one of the things our prescribers try to flag clearly before treatment starts, precisely so the first rough week doesn't catch anyone off guard.
There is a lot of sensible, practical ground between pushing through without any adjustments and stopping the medicine at the first bout of nausea. Most people who persist past the early weeks report symptoms easing considerably.
Food timing matters. Eating smaller portions slowly, avoiding high-fat meals and giving yourself time after injecting before eating can reduce the severity of nausea. Cold or room-temperature foods tend to be easier to tolerate than hot ones for some people. Fizzy drinks often make bloating worse. None of this is complicated, but it does require a temporary change to habits.
Hydration is the priority with diarrhoea. Frequent loose stools can deplete fluids faster than people expect, and dehydration puts strain on the kidneys, which the NHS's semaglutide guidance specifically flags as a risk with severe GI illness on this medicine. Water, diluted electrolyte drinks and clear broth are sensible choices. Alcohol and caffeine are not.
If you're specifically dealing with loose stools as the dominant problem, our page on sickness and diarrhoea on Wegovy covers both symptoms together, while Wegovy and diarrhoea goes into more detail on what helps. For nausea as the main concern, managing Wegovy sickness covers practical steps in more depth.
Do not adjust your dose timing or skip doses without speaking to your prescriber first. The Patient Information Leaflet that comes with your pen is the right reference for storage, missed-dose guidance and other specifics.
Most gut symptoms on Wegovy are uncomfortable but not dangerous. A few are not in that category.
Seek urgent medical assessment if you notice any of the following. Severe stomach pain that is persistent and radiates to the back, with or without vomiting, can be a sign of acute pancreatitis. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting pancreatitis as an infrequent but serious known risk with GLP-1 medicines, the key word in the guidance is persistent. Ordinary nausea passes; this kind of pain does not.
Other signs that warrant same-day attention: symptoms of an allergic reaction (swelling of the face, lips or throat, difficulty breathing, rapid heartbeat), blood in stools or vomit, signs of significant dehydration (very dark urine, dizziness on standing, inability to keep any fluids down), or severe upper-right abdominal pain that might point to gallbladder problems.
If you are unsure whether your symptoms fall into this category, NHS 111 is the right first call. Do not wait for your next review appointment if something feels wrong.
Any side effect you weren't expecting, or that felt more severe than the leaflet suggests, can be reported to the MHRA via the Yellow Card scheme, that reporting genuinely helps regulators monitor real-world safety data for newer medicines.
Side effects after starting or stepping up are worth documenting, even briefly. A note of what happened, on which day, and how long it lasted gives a prescriber something concrete to work with. If symptoms were severe at one dose, there may be a case for a slower titration; if they were manageable, the record confirms the medicine is being tolerated. Either way, your next clinical review is the right place to raise it.
At nume, side effects are part of what our prescribers discuss at consultation, not an afterthought. The Wegovy overview explains the full picture of how treatment works, and our treatment page is where you can check your eligibility and start that conversation. Questions our clinical team hears most often are also covered on the FAQs page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.